Kenneth Traub - 16 Sep 2022 Form 4 Insider Report for ATHERSYS, INC / NEW

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Sep 2022, 13:44:39 UTC
Prior SEC filing
16 Jun 2022
Next SEC filing
28 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Barb Cameron, as attorney-in-fact for Kenneth Traub

Key filing fact

Kenneth Traub filed Form 4 for ATHERSYS, INC / NEW on 20 Sep 2022.

Key facts

  • This page summarizes Kenneth Traub's Form 4 filing for ATHERSYS, INC / NEW.
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Sep 2022, 13:44.

Change

  • Previous filing in this sequence was filed on 16 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATHX transaction

Common Stock

Award

Transaction value
$0
Shares
+12,820
Change %
+136%
Price
$0.000000
Shares after
22,223
Date
16 Sep 2022
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATHX transaction Derivative

Stock Option (right to purchase)

Award

Transaction value
$0
Shares
+32,042
Change %
Price
$0.000000
Shares after
32,042
Date
16 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
32,042
Exercise price
$1.95
Footnotes
F3
ATHX holding Derivative

Stock Option (right to purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,000
Date
16 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,000
Exercise price
$63.25
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the exempt acquisition of 12,820 restricted stock units that in general will vest in total on December 31, 2022, subject generally to the Reporting Person's continued service on the Issuer's Board of Directors.

Footnote F2

On August 26, 2022, the Issuer effected a 1-for-25 reverse stock split of its Common Stock (the "Reverse Stock Split"), resulting in a decrease in the Reporting Person's ownership by 225,690 shares.

Footnote F3

Represents the exempt acquisition of stock options to purchase 32,042 shares of the Issuer's Common Stock at a per share exercise price of $1.95. These stock options in general will vest on July 28, 2023, subject generally to the Reporting Person's continued service on the Issuer's Board of Directors.

Footnote F4

This option has been adjusted to reflect the Reverse Stock Split (in prior reports, this option was previously reported as covering a number of shares equal to this reported amount times 25 (and at an exercise price equal to this reported exercise price divided by 25)).

Footnote F5

Award of a nonqualified stock option. The option vests one-third on February 17, 2022 and thereafter ratably on a quarterly basis over a two-year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .